Human testing of a coronavirus
vaccine developed by a firm near Rome and the University of
Oxford in the UK will start at the end of the month, the company
in Pomezia said at the weekend.
The accelerated tests on 550 healthy volunteers will
hopefully lead to "making the vaccine usable already in
September to vaccine health staff and police", said CEO of
Advent-Irbm, Piero Di Lorenzo, said.
The company south of Rome has developed the vaccine with
Oxford University's Jenner Institute.
ALL RIGHTS RESERVED © Copyright ANSA
